Alterola Biotech, Inc.
ABTI · OTC
3/31/2023 | 3/31/2022 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Market Cap | $35 | $169 | $84 | $142 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $37 | $169 | $84 | $142 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$6 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$6 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.008 | -0.002 | -0.002 |
| % Growth | 77.4% | -460% | 31.8% | – |
| Operating Cash Flow | -$1 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | $0 | $0 | $0 |